SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Jun-24 5:14 PM View: | Uniqure N.V. (QURE) | 19-Jun-24 | Grant | 8,080 | -- | -- | 34% 23.76K to 31.84K | |
17-Jun-24 7:40 PM View: | Uniqure N.V. (QURE) | 13-Jun-24 | Sale | 2,231 | $5.12 | $11,422.70 | (9%) 25.99K to 23.76K | |
01-Mar-23 10:00 PM View: | Uniqure N.V. (QURE) | 27-Feb-23 | Market Sale | 384 | $20.41 | $7,837.44 | (2%) 19.96K to 19.57K | 4% |
17-Jun-22 4:18 PM View: | Uniqure N.V. (QURE) | 15-Jun-22 | Grant | 9,080 | -- | -- | 83% 10.88K to 19.96K | |
02-Mar-22 5:39 PM View: | Uniqure N.V. (QURE) | 28-Feb-22 | Sale | 602 | $16.70 | $10,053.40 | (5%) 11.48K to 10.88K | |
28-Feb-22 6:35 PM View: | Uniqure N.V. (QURE) | 24-Feb-22 | Grant | 1,534 | -- | -- | 15% 9.95K to 11.48K | |
04-Mar-21 1:53 PM View: | Uniqure N.V. (QURE) | 02-Mar-21 | Market Sale | 505 | $37.50 | $18,937.50 | (5%) 10.45K to 9.95K | 7% |
01-Mar-21 4:06 PM View: | Uniqure N.V. (QURE) | 25-Feb-21 | Grant | 2,382 | -- | -- | 30% 8.07K to 10.45K | |
02-Mar-20 3:59 PM View: | Uniqure N.V. (QURE) | 27-Feb-20 | Grant | 2,063 | -- | -- | 34% 6.0K to 8.07K | |
30-Jan-20 8:57 PM View: | Uniqure N.V. (QURE) | 28-Jan-20 | Market Sale | 807 | $62.19 | $50,190.40 | (12%) 6.81K to 6.0K | 39% |
12-Nov-19 4:34 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Nov-19 | Market Purchase (Planned) | 10,121 | $4.97 | $50,268.00 | 41% 24.88K to 35.0K | 135% |
12-Nov-19 4:34 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 11-Nov-19 | Market Purchase (Planned) | 9,879 | $4.99 | $49,327.80 | 66% 15.0K to 24.88K | 134% |
14-Feb-19 5:19 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Feb-19 | Grant | 87,000 | -- | -- | 580% 15.0K to 102.0K | |
30-Jan-19 4:49 PM View: | Uniqure N.V. (QURE) | 28-Jan-19 | Market Sale | 1,210 | $31.32 | $37,897.20 | (15%) 8.02K to 6.81K | (22%) |
29-Jan-19 8:43 PM View: | Uniqure N.V. (QURE) | 25-Jan-19 | Grant | 3,230 | -- | -- | 67% 4.79K to 8.02K | |
30-Jan-18 11:51 AM View: | Uniqure N.V. (QURE) | 26-Jan-18 | Grant | 4,792 | -- | -- | 100% 0 to 4.79K | |
15-Dec-17 4:02 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Dec-17 | Market Purchase | 15,000 | $9.08 | $136,260.00 | 100% 0 to 15.0K | 29% |